AVEO Related Analyst Ratings

May 3, 2013 08:37 AM Stifel Nicolaus Upgrades AVEO Pharmaceuticals (AVEO) to Hold

May 3, 2013 07:15 AM RBC Capital Downgrades AVEO Pharmaceuticals (AVEO) to Sector Perform

May 2, 2013 03:06 PM William Blair Downgrades AVEO Pharmaceuticals (AVEO) to Market Perform

May 2, 2013 02:05 PM JPMorgan Downgrades AVEO Pharmaceuticals (AVEO) to Neutral

May 2, 2013 12:58 PM BMO Capital Downgrades AVEO Pharmaceuticals (AVEO) to Underperform

Apr 30, 2013 10:44 AM AVEO Pharma's (AVEO) Tivozanib Needs Second Trial; Leerink Swann Comments

Apr 2, 2013 07:44 AM JMP Securities Starts AVEO Pharmaceuticals (AVEO) at Market Perform

Feb 14, 2013 12:45 PM Jefferies Cuts PT on AVEO Pharmaceuticals (AVEO); More Cautious on Tivo Approval

Nov 14, 2012 07:24 AM Stifel Nicolaus Starts AVEO Pharmaceuticals (AVEO) at Sell

Oct 8, 2012 10:02 AM Leerink Swann Downgrades AVEO Pharmaceuticals (AVEO) to Market Perform, Cites Tivozanib Risks

Aug 15, 2012 09:46 AM Jefferies maintains a 'Hold' on AVEO Pharmaceuticals (AVEO); Update From 2012 Boston Healthcare Summit

Aug 3, 2012 10:23 AM Canaccord Genuity on AVEO Pharmaceuticals (AVEO): FDA Concern on OS Rrend May Delay TIVO Filing

Aug 3, 2012 07:15 AM Jefferies Downgrades AVEO Pharmaceuticals (AVEO) to Hold; Regulatory Risk Rises

Jun 4, 2012 07:42 AM Jefferies Reiterates Bullish View on AVEO Pharmaceuticals (AVEO) Following TIVO-1 Data

May 4, 2012 11:39 AM Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); Q1 In-line; Waiting on P3 TIVO-1 Data at ASCO

Apr 30, 2012 07:39 AM Canaccord Genuity Assumes Coverage on AVEO Pharmaceuticals (AVEO) at Buy

Mar 13, 2012 08:04 AM BMO Capital Starts AVEO Pharmaceuticals (AVEO) at Market Perform

Feb 15, 2012 09:46 AM Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); Awaiting TIVO-1 ASCO Presentation

Feb 10, 2012 07:04 AM Morgan Stanley Starts AVEO Pharmaceuticals (AVEO) at Equalweight

Jan 13, 2012 08:56 AM Canaccord Biotech Meeting Takeaways Part I: ANAC, AVEO & EXEL

Jan 4, 2012 09:05 AM Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); Conflicting TIVO-1 Data Clouds RCC Competitive Landscape

Nov 28, 2011 09:21 AM Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); ODAC Vote Could Shape Future RCC Treatment Landscape

Aug 18, 2011 09:18 AM Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); 2012 A Critical Year

Jul 6, 2011 07:17 AM Jefferies Starts AVEO Pharmaceuticals (AVEO) at Buy

Jun 29, 2011 08:25 AM William Blair Starts AVEO Pharmaceuticals (AVEO) at Outperform

Jun 7, 2011 08:41 AM Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); Tivo Still Positioned Well in the Face of Decent Axitinib Data

Jun 1, 2011 08:51 AM Canaccord Genuity Reiterates a 'Buy' on AVEO Pharmaceuticals (AVEO); License Agreement Supports Platform Potential

May 19, 2011 11:05 AM Canaccord Genuity Reiterates a 'Buy' on AVEO Pharmaceuticals (AVEO); AXIS Subgroup Results Support TIVO Success

Feb 28, 2011 11:35 AM Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); Model Updates Following Tivo Deal

Feb 17, 2011 03:18 PM Canaccord Genuity Reiterates a 'Buy' on AVEO Pharmaceuticals (AVEO); Rich Tivo Deal Validates Commercial Potential

Dec 28, 2010 09:35 AM Canaccord Genuity on Life Sciences/Biotechnology: Selected Small Cap Biotech Roundup

Nov 29, 2010 05:34 PM RBC Capital Starts AVEO Pharma (AVEO) at Outperform, Sets $24 Price Target

Oct 6, 2010 11:44 AM Canaccord Genuity Reiterates a 'Buy' on AVEO Pharmaceuticals (AVEO); AV-299 Return Diversifies Risk Profile

Apr 28, 2010 08:07 AM Leerink Swann Initiates Coverage on AVEO Pharmaceuticals (AVEO) with an Outperform

Apr 21, 2010 10:05 AM Morgan Stanley Initiates Coverage on AVEO Pharmaceuticals (AVEO) with an Outperform

Apr 21, 2010 09:59 AM Canaccord Adams Initiates Voverage on AVEO Pharmaceuticals (AVEO) with a Buy; Best-in-Class Cancer Drug Moves Forward

Apr 21, 2010 09:13 AM J.P. Morgan Initiates Coverage on AVEO Pharmaceuticals (AVEO) with an Overweight